Paper

Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors

Published Jul 1, 2024 · Adeshina I Odugbemi, Clement N. Nyirenda, Alan Christoffels

Computational and Structural Biotechnology Journal

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Literature Review

Study Snapshot

Artificial intelligence, specifically QSAR analysis, has revolutionized antidiabetic drug discovery by predicting the biological activity of new compounds against various biological targets, including -glucosidase inhibitors.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors

References

Citations